Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.68M | 4.77M | 4.87M | 3.55M | 2.24M |
| Total Depreciation and Amortization | 6.02M | 6.27M | 6.54M | 6.56M | 6.60M |
| Total Amortization of Deferred Charges | 821.00K | 825.70K | 833.30K | 807.40K | 784.40K |
| Total Other Non-Cash Items | 1.59M | 1.20M | 830.10K | 813.90K | 786.20K |
| Change in Net Operating Assets | 5.34M | 4.33M | 3.35M | 3.35M | 3.35M |
| Cash from Operations | 18.45M | 17.39M | 16.42M | 15.07M | 13.76M |
| Capital Expenditure | -3.22M | -3.42M | -3.63M | -3.24M | -2.85M |
| Sale of Property, Plant, and Equipment | 32.60K | 153.80K | 275.80K | 281.90K | 288.00K |
| Cash Acquisitions | -- | 196.00K | 393.00K | 393.00K | 393.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.37M | 1.43M | 1.48M | 2.12M | 2.78M |
| Cash from Investing | -1.81M | -1.64M | -1.48M | -440.50K | 609.10K |
| Total Debt Issued | 389.73M | 354.56M | 319.40M | 311.27M | 303.14M |
| Total Debt Repaid | -433.62M | -410.97M | -388.32M | -387.94M | -387.56M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.02M | -14.31M | -14.60M | -15.75M | -16.90M |
| Cash from Financing | -8.03M | -9.79M | -11.58M | -12.81M | -14.08M |
| Foreign Exchange rate Adjustments | -91.60K | -600.00 | 90.30K | 123.60K | 157.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.51M | 5.95M | 3.44M | 1.95M | 439.30K |